CMR Surgical, the global surgical robotics business, announces the appointment of Daniel (Dan) Moore as Non-Executive Chairman of the Board of Directors, effective immediately.
Dan Moore is a seasoned executive with over 35 years of both executive and board leadership experience from several globally renowned medical technology companies, including Boston Scientific. Dan was most recently the Chairman of the Board at LivaNova, a medical devices company developing and marketing neuromodulation and cardiopulmonary products to help improve patients’ lives.
Prior to the merger of Sorin and Cyberonics to form LivaNova, Dan was the President and CEO of Cyberonics for eight years. He has also been an established Board level executive in the MedTech industry, and served as Chairman at Brainscope, GI Dynamics and the Medical Device Manufacturers Association (MDMA), as well as serving on the Board of the Epilepsy Foundation.
Dan first established his medical devices career at Boston Scientific where he served for nearly 20 years, having held several senior executive roles, including President of Inter-Continental and Distribution Management.
As Chairman, Dan will lead the CMR Surgical Board and work alongside CMR’s board members and executive leadership team, as they continue to drive the company’s growth strategy and bring Versius to more hospitals around the world to make minimal access surgery available to all patients who need it.
Supratim Bose, Chief Executive Officer of CMR Surgical, commented: “Daniel has exceptional experience leading medical technology organisations, and a passion for how technology can help transform the lives of patients. His significant sector experience, combined with his strong executive and board level leadership, will be invaluable to CMR as we continue to partner with more hospitals around the world, bringing the benefits of robotic-assisted surgery to more patients.”
Umur Hursever, Partner at Lightrock and Interim Chairman commented: “On behalf of the Board, I am delighted to welcome Daniel Moore as Chairman of CMR Surgical. CMR has now established itself in the surgical robotics space and I know with Daniel’s experience the Company will be in an even stronger place to capitalise on a fast-growing market and deliver against its mission.”
John Cassidy, Investment Director, Softbank Investment Advisers and Interim Vice Chair commented: “We are pleased to have someone of Dan’s stature join as Chair of the Board. We have a real opportunity to increase access to robotic-assisted surgery with Versius and I believe Dan’s deep MedTech experience will be a substantial asset in ensuring CMR achieves its mission.”
Dan Moore, Non-Executive Chairman at CMR Surgical, added: “The surgical robotics sector is one of the most exciting in the MedTech space and Versius is a truly differentiated technology with many large untapped markets yet to be reached, and more patients to be served. I look forward to working with the Board, Supratim and the leadership team to help realise the vision of the company and true promise of Versius.”
